Zentalis Pharmaceuticals, Inc.
- Biotech or pharma, therapeutic R&D
Clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other tumor types.
June 16-19, 2025
Boston Convention & Exhibition Center
BIO DOUBLE HELIX SPONSORS
Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.
)
)
)
)
){kind=logo}
){kind=logo}
)
BIO HELIX SPONSORS
){kind=logo}
)
){kind=logo}